Long-Term 3-Year Efficacy of Dupilumab in QUEST Patients Enrolled in LIBERTY ASTHMA TRAVERSE

被引：0
|
作者：
Papi, A. [1 ]
Bourdin, A. [2 ]
Watz, H. [3 ]
Pavord, I. D. [4 ]
Domingo, C. [5 ]
Wechsler, M. E. [6 ]
Mao, X. [7 ]
Ortiz, B. [8 ]
Djandji, M. [9 ]
Mannent, L. P. [10 ]
Ruddy, M. [8 ]
Laws, E. [7 ]
Amin, N. [8 ]
Lederer, D. J. [8 ]
Hardin, M. [9 ]
机构：
[1] Univ Ferrara, S Anna Univ Hosp, Resp Med Unit, Ferrara, Italy
[2] Montpellier Univ Hosp, Montpellier, France
[3] German Ctr Lung Res DZL, Airway Res Ctr North ARCN, LungenClin Grosshansdorf, Pulm Res Inst, Grosshansdorf, Germany
[4] Univ Oxford, NIHR Oxford Biomed Res Ctr, Oxford, England
[5] Autonomous Univ Barcelona, Sabadell, Corp Sanitaria Parc Tauli, Barcelona, Spain
[6] Natl Jewish Hlth, Denver, CO USA
[7] Sanofi, Bridgewater, NJ USA
[8] Regeneron Pharmaceut Inc, 777 Old Saw Mill River Rd, Tarrytown, NY 10591 USA
[9] Sanofi, Cambridge, MA USA
[10] Sanofi, Chilly Mazarin, France
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2021年 / 203卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1460
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Assessment of the long-term safety and efficacy of dupilumab in children with asthma: LIBERTY ASTHMA EXCURSION
    Bacharier, L.
    Maspero, J. F.
    Katelaris, C. H.
    Fiocchi, A.
    Gagnon, R.
    De Mir-Messa, I
    Guilbert, T. W.
    Jackson, D. J.
    Li, N.
    Akinlade, B.
    Laws, E.
    Mannent, L. P.
    Maloney, J.
    Tawo, K.
    Khokhar, F. A.
    Hardin, M.
    Abdulai, R. M.
    Lederer, D. J.
    Robinson, L.
    EUROPEAN RESPIRATORY JOURNAL, 2022, 60
  • [22] Assessment of the long-term safety and efficacy of dupilumab in children with asthma: LIBERTY ASTHMA EXCURSION
    Leonard, Bacharier B.
    Jorge, Maspero F.
    Constance, Katelaris H.
    Alessandro, Fiocchi G.
    Remi, Gagnon
    Ines, de Mir-Messa
    Theresa, Guilbert W.
    Daniel, Jackson J.
    Eckard, Hamelmann
    Ning, Li
    Bolanle, Akinlade
    Elizabeth, Laws
    Leda, Mannent P.
    Jennifer, Maloney
    Kelsey, Tawo T.
    Faisal, Khokhar A.
    Megan, Hardin
    Raolat, Abdulai M.
    David, Lederer J.
    Lacey, Robinson B.
    KLINISCHE PADIATRIE, 2023, 235 (02): : 110 - 110
  • [23] Long-term Safety and Efficacy of Dupilumab in Patients With Uncontrolled, Moderate-to-Severe Asthma Recruited From Korean Centers: A Subgroup Analysis of the Phase 3 LIBERTY ASTHMA TRAVERSE Trial
    Rhee, Chin Kook
    Park, Jung-Won
    Park, Heung-Woo
    Noh, Hayeon
    Msihid, Jerome
    Cho, You Sook
    ALLERGY ASTHMA & IMMUNOLOGY RESEARCH, 2024, 16 (04) : 372 - 386
  • [24] ASSESSMENT OF THE LONG-TERM SAFETY AND EFFICACY OF DUPILUMAB IN CHILDREN WITH ASTHMA (LIBERTY ASTHMA EXCURSION STUDY)
    Bacharier, Leonard B.
    Maspero, Jorge F.
    Katelaris, Connie H.
    Fiocchi, Alessandro
    Gagnon, Remi
    De Mir-Messa, Ines
    Guilbert, Theresa W.
    Jackson, Daniel J.
    Li, Ning
    Akinlade, Bolanle
    Laws, Elizabeth
    Mannent, Leda L. M.
    Maloney, Jennifer
    Tawo, Kelsey
    Khokhar, Faisal A.
    Hardin, Megan
    Abdulai, Raolat
    Lederer, David J.
    Robinson, Lacey B.
    CHEST, 2022, 162 (04) : 2677A - 2679A
  • [25] Type 2 Biomarkers Associated with Dupilumab Efficacy in Patients with Uncontrolled, Moderate-To-Severe Asthma Enrolled in the Phase 3 Study LIBERTY ASTHMA QUEST
    Wenzel, S. E.
    Pavord, I.
    Zhang, B.
    Maroni, J.
    Rowe, P.
    Hamilton, J. D.
    Swanson, B. N.
    Amin, N.
    Pirozzi, G.
    Graham, N. M.
    Teper, A.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2018, 197
  • [26] Effect of Dupilumab on Lung Function Parameters in Oral Corticosteroid-Dependent Patients With Asthma Enrolled in LIBERTY ASTHMA TRAVERSE
    Castro, M.
    Papi, A.
    Corren, J.
    Pavord, D., I
    Tohda, Y.
    Xuezhou, M.
    Ortiz, B.
    Djandji, M.
    Ruddy, M.
    Laws, E.
    Mannent, P. L.
    Amin, N.
    Gall, R.
    Jacob-Nara, A. J.
    Deniz, Y.
    Rowe, J. P.
    Atenhan, A.
    Thakur, M.
    Lederer, J. D.
    Hardin, M.
    PNEUMOLOGIE, 2022, 76 : S41 - S41
  • [27] EFFECT OF DUPILUMAB ON LUNG FUNCTION PARAMETERS IN ORAL CORTICOSTEROID-DEPENDENT PATIENTS WITH ASTHMA ENROLLED IN LIBERTY ASTHMA TRAVERSE
    Castro, Mario
    Papi, Alberto
    Corren, Jonathan
    Pavord, Ian
    Tohda, Yuji
    Mao, Xuezhou
    Ortiz, Benjamin
    Djandji, Michel
    Ruddy, Marcella
    Laws, Elizabeth
    Mannent, Leda
    Amin, Nikhil
    Gall, Rebecca
    Jacob-Nara, Juby
    Deniz, Yamo
    Rowe, Paul
    Lederer, David
    Hardin, Megan
    CHEST, 2021, 160 (04) : 1877A - 1881A
  • [28] Long-Term Efficacy of Dupilumab in Quadrants of Elevated- vs Low- Type 2 Biomarker Patients With Uncontrolled, Moderate-to-Severe Asthma: LIBERTY ASTHMA TRAVERSE
    Wechsler, Michael
    Pavord, Ian
    Papi, Alberto
    Chapman, Kenneth
    Mao, Xuezhou
    Ortiz, Benjamin
    Djandji, Michel
    Jacob-Nara, Juby
    Rowe, Paul
    Deniz, Yamo
    Laws, Elizabeth
    Akinlade, Bolanle
    Amin, Nikhil
    Lederer, David
    Hardin, Megan
    JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2022, 149 (02) : AB190 - AB190
  • [29] Impact of early transient increase in eosinophils in patients with moderate-to-severe asthma on the long-term efficacy of dupilumab in TRAVERSE
    Pavord, Ian Douglas
    Lugogo, Njira L.
    Castro, Mario
    Papi, Alberto
    Bourdin, Arnaud
    Wechsler, Michael E.
    Cote, Andreanne
    Xia, Changming
    Soliman, Mena
    Pandit-Abid, Nami
    Jacob-Nara, Juby A.
    Sacks, Harry
    EUROPEAN RESPIRATORY JOURNAL, 2024, 64
  • [30] Long-Term Dupilumab Treatment in Moderate-to-Severe Asthma with Type 2 Inflammation: Open Label LIBERTY ASTHMA TRAVERSE Study
    Wechsler, M.
    Pavord, I. D.
    Papi, A.
    Chapman, K. R.
    Mao, X.
    Ortiz, B.
    Djandji, M.
    Ruddy, M. K.
    Laws, E.
    Amin, N.
    Lederer, D. J.
    Hardin, M. E.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
12345